PDE5A and erectile dysfunction: The mainstay of the therapeutic approach to erectile dysfunction is pharmacological treatment, which involves the individual selection of agents that influence the biochemical pathways responsible for increasing blood flow to the penis, most often phosphodiesterase type 5 (PDE-5) inhibitors, such as sildenafil and tadalafil [10,11].